Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.56 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 5/20 | 0.44 |
| ▸ | F2 | P00734 | 4/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.40 |
| ▸ | MMP2 | P08253 | 1/20 | 0.40 |
| ▸ | MMP9 | P14780 | 1/20 | 0.40 |
| ▸ | MMP12 | P39900 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17894362 | 0.79 | AGXT (0.57) | RAB9AF2MMP2MMP9MMP12 | |
| SCHEMBL1741620 | 0.78 | NPC1 (0.56) | IDO1RAB9A | |
| Hydrochloric Acid SCHEMBL28129374 | 0.77 | NPC1 (0.55) | IDO1RAB9A | |
| SCHEMBL13938654 | 0.77 | IDO1 (0.60) | IDO1TAAR1RAB9APOLBMAOB | |
| SCHEMBL24211764 | 0.77 | TAAR1 (0.53) | IDO1TAAR1POLBNR3C2 | |
| SCHEMBL17894428 | 0.76 | F10 (0.49) | MAOBF2MMP2MMP9MMP12 | |
| SCHEMBL10648740 | 0.76 | TAAR1 (0.56) | IDO1TAAR1 | |
| SCHEMBL10107046 | 0.75 | IDO1 (0.58) | IDO1TAAR1RAB9APOLBMAOB | |
| SCHEMBL24067485 | 0.75 | IDO1 (0.58) | IDO1TAAR1RAB9APOLBMAOB | |
| Acetic Acid SCHEMBL27764846 | 0.75 | NPC1 (0.57) | RAB9AMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170342025-A1 | ANTIMICROBIAL COMPOUNDS, COMPOSITIONS AND METHODS | THE UNIVERSITY OF BATH (GB) | 2017-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170342025-A1 | ANTIMICROBIAL COMPOUNDS, COMPOSITIONS AND METHODS | ZYX, MPO, CFB | IDO1 794/4885TAAR1 4285/4885RAB9A 1751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.